Cardiac hypertrophy in deceased users of anabolic androgenic steroids: An investigation of autopsy findings

Cardiovascular Pathology

Volumn 21, Issue 4, 2012, Pages 312-316

  Far, Hamid Reza Mobini ^a   Ågren, Greta ^a   Thiblin, Ingemar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anabolic androgenic steroids; Cardiac death; Drug abuse; Pathological cardiac hypertrophy

Indexed keywords

STEROID;

AGE; ARTICLE; AUTOPSY; BLEEDING; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DEATH; HEART LEFT VENTRICLE HYPERTROPHY; HEART VOLUME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TRAINING;

ANABOLIC AGENTS; ANDROGENS; AUTOPSY; BODY WEIGHT; CAUSE OF DEATH; DEATH, SUDDEN; FORENSIC PATHOLOGY; HEART; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; ORGAN SIZE; SUBSTANCE-RELATED DISORDERS; SWEDEN;

EID: 84863722465     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2011.10.002     Document Type: Article

References (27)

1. MC Kennedy, and C Lawrence Anabolic steroid abuse and cardiac death Med J Aust 158 1993 346 348
2. V Fineschi, I Riezzo, F Centini, E Silingardi, M Licata, and G Beduschi Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders Int J Legal Med 121 2007 48 53
3. RD Dickerman, F Schaller, I Prather, and WJ McConathy Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids Cardiology 86 1995 172 173
4. C Mewis, I Spyridopoulos, V Kuhlkamp, and L Seipel Manifestation of severe coronary heart disease after anabolic drug abuse Clin Cardiol 19 1996 153 155
5. RA McNutt, GS Ferenchick, PC Kirlin, and NJ Hamlin Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids Am J Cardiol 62 1988 164
6. C Kennedy Myocardial infarction in association with misuse of anabolic steroids Ulster Med J 62 1993 174 176
7. K Cheever, and MA House Cardiovascular implications of anabolic steroid abuse J Cardiovasc Nurs 6 1992 19 30
8. M Alen, and P Rahkila Reduced high-density lipoprotein-cholesterol in power athletes: use of male sex hormone derivates, an atherogenic factor Int J Sports Med 5 1984 341 342
9. JW Lenders, PN Demacker, JA Vos, PL Jansen, AJ Hoitsma, and A van 't Laar Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders Int J Sports Med 9 1988 19 23
10. OL Webb, PM Laskarzewski, and CJ Glueck Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids Metabolism 33 1984 971 975
11. CJ Bagatell, JR Heiman, AM Matsumoto, JE Rivier, and WJ Bremner Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men J Clin Endocrinol Metab 79 1994 561 567
12. U Zuliani, B Bernardini, A Catapano, M Campana, G Cerioli, and M Spattini Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body builders Int J Sports Med 10 1989 62 66
13. A Urhausen, R Holpes, and W Kindermann One- and two-dimensional echocardiography in bodybuilders using anabolic steroids Eur J Appl Physiol Occup Physiol 58 1989 633 640
14. B De Piccoli, F Giada, A Benettin, F Sartori, and E Piccolo Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function Int J Sports Med 12 1991 408 412
15. TA Karila, JE Karjalainen, MJ Mantysaari, MT Viitasalo, and TA Seppala Anabolic androgenic steroids produce dose-dependant increase in left ventricular mass in power athletes, and this effect is potentiated by concomitant use of growth hormone Int J Sports Med 24 2003 337 343
16. V Di Bello, D Giorgi, M Bianchi, A Bertini, MT Caputo, and G Valenti Effects of anabolic-androgenic steroids on weight-lifters' myocardium: an ultrasonic videodensitometric study Med Sci Sports Exerc 31 1999 514 521
17. P Palatini, F Giada, G Garavelli, F Sinisi, L Mario, and M Michieletto Cardiovascular effects of anabolic steroids in weight-trained subjects J Clin Pharmacol 36 1996 1132 1140
18. PD Thompson, A Sadaniantz, EM Cullinane, KS Bodziony, DH Catlin, and G Torek-Both Left ventricular function is not impaired in weight-lifters who use anabolic steroids J Am Coll Cardiol 19 1992 278 282
19. F Hartgens, EC Cheriex, and H Kuipers Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes Int J Sports Med 24 2003 344 351
20. I Thiblin, O Lindquist, and J Rajs Cause and manner of death among users of anabolic androgenic steroids J Forensic Sci 45 2000 16 23
21. A Petersson, M Garle, P Holmgren, H Druid, P Krantz, and I Thiblin Toxicological findings and manner of death in autopsied users of anabolic androgenic steroids Drug Alcohol Depend 81 2006 241 249
22. A Petersson, M Garle, F Granath, and I Thiblin Morbidity and mortality in patients testing positively for the presence of anabolic androgenic steroids in connection with receiving medical care. A controlled retrospective cohort study Drug Alcohol Depend 81 2006 215 220
23. Y Ito, R Tsuda, and M Hara The weight ratio of organs for 750 judicial autopsy cases Igaku Kenkyu 59 1989 60 62
24. JA Hadley, and DR Fowler Organ weight effects of drowning and asphyxiation on the lungs, liver, brain, heart, kidneys, and spleen Forensic Sci Int 137 2003 239 246
25. A Urhausen, T Albers, and W Kindermann Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90 2004 496 501
26. I Thiblin, and A Petersson Pharmacoepidemiology of anabolic androgenic steroids: a review Fundam Clin Pharmacol 19 2005 27 44
27. DW Kitzman, DG Scholz, PT Hagen, DM Ilstrup, and WD Edwards Age-related changes in normal human hearts during the first 10 decades of life. Part II (maturity): a quantitative anatomic study of 765 specimens from subjects 20 to 99 years old Mayo Clin Proc 63 1988 137 146